大腸がんの神経新生性進行におけるネクサスの解明:β2-アドレナリン受容体 (β2-AR) の潜在的な役割
Elizabeth Varghese1, Samson Mathews Samuel1, Slavomir Hornak2
1Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha P.O. Box 24144, Qatar.
Journal of advanced research
|September 6, 2025
まとめ
結腸直腸がん細胞のβ2- アドレナジック受容体 (β2- AR) は,神経信号と腫瘍の成長を結びつける. β2- ARをターゲットにすることで,大腸がん (大腸がん) の新しい治療戦略が提供される可能性があります.
科学分野:
- 腫瘍学
- 神経科学
- 分子生物学
背景:
- 腫瘍の微小環境 (TME) には,がん細胞と周囲の非がん細胞の相互作用が含まれています.
- 腫瘍に関連したニューロンは,神経伝達物質の放出と神経繊維の浸透によって癌の進行に影響します.
- ベータ2- アドレナゲン受容体 (β2- AR) は結腸直腸がん (CRC) で発現し,カテコアミンなどの神経向性因子に反応する.
研究 の 目的:
- 大腸がんの進行における神経がん軸におけるβ2-ARの役割を検討する.
- CRCの診断,予後,および治療におけるβ2-ARの臨床的関連性を調査する.
主な方法:
- 大腸がんにおけるβ2-ARの発現と機能に焦点を当てた文献レビュー.
- 癌経路,免疫調節,転移に対するアドレナージ信号の影響を分析する.
- β2-ARを潜在的バイオマーカーと治療標的として評価する.
主要な成果:
- CRC細胞と大腸内TMEにおけるβ2-AR発現は有意である.
- アドレナジックシグナル伝達,特にストレス誘発によるカテキオラミンの放出は,CRCの成長を促す腫瘍学的経路を活性化することができます.
- β2- AR ターゲティングは免疫反応を調節し,転移を抑制する.
結論:
- β2-ARは,大腸がんにおける神経新生体シグナル伝達において重要な役割を果たします.
- β2-ARを標的とし,ベータブロッカーの再利用によって,現在のCRC治療を強化することができる.
- β2-ARは,CRCの患者のアウトカムを改善するための有望なバイオマーカーであり,治療目標です.
関連する概念動画
Non-Canonical Wnt Signaling Pathways
7.4K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
Canonical Wnt Signaling Pathway
8.9K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K


